VCYT — VERACYTE, INC.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1384101 ·
Last close
$45.43
Market Cap
$3.65B
52W High
$60.91
52W Low
$29.45
ADV30
1,430,710
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 139,071,000 | 101,159,000 | 22,646,000 | 28,707,000 | 1,436,400,000 | 263,136,000 | 91,994,000 |
| Dec 2025 | 140,636,000 | 101,973,000 | 39,908,000 | 41,149,000 | 1,406,019,000 | 362,578,000 | 96,443,000 |
| Sep 2025 | 131,872,000 | 91,282,000 | 23,112,000 | 19,137,000 | 1,367,787,000 | 315,573,000 | 110,120,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$166,160,000
Investing CF
$-85,352,000
Financing CF
$-4,367,000
CapEx
$-10,820,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$1.41
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-348,923,000
Inventory
$21,416,000
Receivables
$50,112,000
ST Investments
$175,924,000
EBIT TTM
$90,747,000
Pretax Income TTM
$90,747,000
Interest Exp TTM
$0
Analysts
10
Yahoo Snapshot (yfinance, live)
Total Revenue
$561,900,032
EBITDA
$113,515,000
Free Cash Flow
$106,230,872
Enterprise Value
$2,840,444,160
Total Cash
$485,232,000
Total Debt
$40,107,000
Shares Out
80,390,731
Trailing EPS
$1.40
Book Value
$17.28
ROE
8.8%
ROA
4.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 517,145,000 | 78,282,000 | 66,353,000 | 1,406,019,000 | 96,443,000 | 1,309,576,000 | 136,307,000 |
| Dec 2024 | 445,764,000 | 19,510,000 | 24,138,000 | 1,300,035,000 | 124,069,000 | 1,175,966,000 | 75,096,000 |
| Dec 2023 | 361,051,000 | -17,446,000 | -74,404,000 | 1,114,906,000 | 70,804,000 | 1,044,102,000 | 44,222,000 |
| Dec 2022 | 296,536,000 | -35,340,000 | -36,560,000 | 1,156,422,000 | 81,222,000 | 1,075,200,000 | 7,535,000 |
TTM Snapshot
Revenues TTM
$396,033,000
NetIncome TTM
$-16,139,000
OpCashFlow TTM
$0
Assets (Latest)
$1,406,019,000
Forward EPS
$1.95
Max Pain — expiry 2026-12-18
max pain strike: $35.00 · spot: $45.43 · call oi: 2,627 · put oi: 90
Expected Move to 2026-12-18:
±$9.65
(21.24%) —
implied range
$35.78 –
$55.08
· ATM straddle on $45.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NHC | NATIONAL HEALTHCARE CORP | $3.56B | $227.36 | — |
| OPCH | Option Care Health, Inc. | $3.46B | $23.07 | — |
| CELC | Celcuity Inc. | $3.89B | $79.52 | — |
| CDNA | CareDx, Inc. | $3.29B | $63.68 | — |
| CON | Concentra Group Holdings Parent, Inc. | $4.46B | $35.01 | — |
News headlines (Yahoo Finance, 1h cache)
Veracyte Announces Eight Decipher-Focused Studies to Be Presented at ASTRO 2026
2026-09-25 21:12 · Yahoo
Veracyte (VCYT) Surges 10.8%: Is This an Indication of Further Gains?
2026-09-25 13:29 · Yahoo
Beyond Meta, Cathie Wood’s ARKG Loads Up On These 4 Biotech Names
2026-09-22 11:10 · Yahoo
Veeva Unveils AI Study Builder Agent to Speed Clinical Trial Setup
2026-09-25 14:53 · Yahoo
RVTY Launches New Kit in Europe for Newborn Type 1 Diabetes Detection
2026-09-25 13:09 · Yahoo
Here's Why You Should Retain Glaukos Stock in Your Portfolio for Now
2026-09-24 15:46 · Yahoo
Here's Why You Should Hold QIAGEN Stock in Your Portfolio for Now
2026-09-24 15:46 · Yahoo
Illumina Stock Surges 94.9% YTD: What's Behind the Rally?
2026-09-24 13:45 · Yahoo
Here's Why You Should Retain Baxter Stock in Your Portfolio for Now
2026-09-24 13:42 · Yahoo
COO Unveils New Innovation Hub & Lens Launch Plans to Aid CooperVision
2026-09-24 13:31 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.